Does Renal Clearance Differ Between the B-Type Natriuretic Peptides (BNP Versus NT-proBNP)?

Journal of the American College of Cardiology

Volumn 53, Issue 10, 2009, Pages 891-892

  Palmer, Suetonia C ^a   Richards, A Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

BNP; kidney; natriuretic peptides; NT proBNP; renal function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ANGIOGRAPHY; CARDIOVASCULAR DISEASE; CREATININE CLEARANCE; DISEASE MARKER; EDITORIAL; GLOMERULUS FILTRATION RATE; HEART HEMODYNAMICS; HEART MUSCLE TENSION; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY CIRCULATION; KIDNEY CLEARANCE; KIDNEY FUNCTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; RISK ASSESSMENT;

BIOLOGICAL MARKERS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RENAL PLASMA FLOW;

EID: 60949103734     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.11.031     Document Type: Editorial

References (10)

1. Meguid El Nahas A., and Bello A.K. Chronic kidney disease: the global challenge. Lancet 365 (2005) 331-340
2. Lainchbury J.G., Nicholls M.G., Espiner E.A., Ikram H., Yandle T.G., and Richards A.M. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man. Clin Sci 95 (1998) 547-555
3. van Kimmenade R.R.J., Januzzi J.L., Bakker J.A., et al. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide: a mechanistic study of hypertensive subjects. J Am Coll Cardiol 53 (2009) 884-890
4. Richards M., Nicholls M.G., Espiner E.A., et al. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 47 (2006) 52-60
5. Luchner A., Hengstenberg C., Lowel H., Riegger G., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46 (2005) 118-123
6. DeFilippi C., Seliger S.L., Maynard S., and Christenson R.H. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 53 (2007) 1511-1519
7. Hunt P.J., Richards A.M., Nicholls M.G., Yandle T.G., Doughty R.N., and Espiner E.A. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 47 (1997) 287-296
8. Schou M., Dalsgaard M.K., Clemmesen O., et al. Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol 99 (2005) 1676-1680
9. Goetze J.P., Jensen G., Moller S., Bendtsen F., Rehfeld J.F., and Henriksen J.H. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 36 (2006) 8-15
10. Ng L.L., Loke I.W., Davies J.E., et al. Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides. J Am Coll Cardiol 45 (2005) 1043-1050